Berlin, Germany

Arndt Schottelius

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arndt Schottelius. Retrieved from https://idiyas.com/inventor/arndt-schottelius

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arndt Schottelius: Innovator in Nonsteroidal Anti-inflammatory Agents

Introduction

Arndt Schottelius is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nonsteroidal anti-inflammatory agents. His work has had a lasting impact on pain management and inflammation treatment.

Latest Patents

Arndt Schottelius holds a patent for nonsteroidal anti-inflammatory agents. This innovation is crucial for providing alternative options for patients seeking relief from pain and inflammation without the use of steroids. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Schottelius has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His role at the company has allowed him to work on groundbreaking research and development projects that have contributed to the healthcare industry.

Collaborations

Arndt Schottelius has collaborated with esteemed colleagues such as Stefan Jaroch and Manfred Lehmann. These partnerships have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical research.

Conclusion

Arndt Schottelius is a distinguished inventor whose work in nonsteroidal anti-inflammatory agents has made a significant impact in the medical field. His contributions continue to influence the development of effective treatments for pain and inflammation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…